Details

Autor(en) / Beteiligte

• Shea, Yat-Fung
• Barker, Warren
• Greig-Gusto, Maria T
• Loewenstein, David A
• Duara, Ranjan
• DeKosky, Steven T
• Hornberger, Michael

Titel

Impact of Amyloid PET Imaging in the Memory Clinic: A Systematic Review and Meta-Analysis

Ist Teil von

• Journal of Alzheimer's disease, 2018-01, Vol.64 (1), p.323-335

Ort / Verlag

Netherlands

Erscheinungsjahr

2018

Quelle

MEDLINE

Beschreibungen/Notizen

• Patients with cognitive impairment or dementias of uncertain etiology are frequently referred to a memory disorders specialty clinic. The impact of and role for amyloid PET imaging (Aβ-PET) may be most appropriate in this clinical setting. The primary objective of this study was to perform a systematic review and meta-analysis of the impact of Aβ-PET on etiological diagnosis and clinical management in the memory clinic setting. A search of the literature on the impact of Aβ-PET in the memory clinic setting between 1 January 2004 and 12 February 2018 was conducted. Meta-analysis using a random effects model was performed to determine the pooled estimate of the impact of Aβ-PET in the changes of diagnoses and changes in management plan. After rigorous review, results from 13 studies were extracted, involving 1,489 patients. Meta-analysis revealed a pooled effect of change in diagnoses of 35.2% (95% CI 24.6-47.5). Sub-analyses showed that the pooled effect in change in diagnoses if Aβ-PET was used under the appropriate use criteria (AUC) or non-AUC criteria were 47.8% (95% CI 25.9-70.5) and 29.6% (95% CI: 21.5-39.3), respectively. The pooled effect of a change of diagnosis from Alzheimer's disease (AD) to non-AD and from non-AD to AD were 22.7% (95% CI: 17.1-29.5) and 25.6% (95% CI: 17.6-35.8), respectively. The pooled effect leading to a change of management was 59.6% (95% CI 39.4-77.0). Aβ-PET has a highly significant impact on both changes in diagnosis and management among patients being seen at a specialty memory clinic.